Evidence map›Paper›PMID 35486953›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

The Impact of Vitamin A Deficiency on Tuberculosis Progression.

Brendan K Podell, Omowunmi Aibana, Chuan-Chin Huang, James E DiLisio, Macallister C Harris, David F Ackart, Kody Armann, Alexander Grover, Patrice Severe, Marc Antoine Jean Juste and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Many Hosts of Mycobacteria 9 (MHM9): A conference report.Tuberculosis (Edinburgh, Scotland) · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Brendan K PodellMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Omowunmi AibanaDepartment of Internal Medicine, McGovern Medical School, Houston, Texas, USA.ORCID 0000-0003-0665-5393
Chuan-Chin HuangDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
James E DiLisioMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Macallister C HarrisMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
David F AckartMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Kody ArmannMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Alexander GroverMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Patrice SevereHaitian group for the study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO) Centers, Port au Prince, Haiti.
Marc Antoine Jean JusteHaitian group for the study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO) Centers, Port au Prince, Haiti.
Kathryn DupnikDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, New York, USA.
Randall J BasarabaMycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Megan B MurrayDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Colorado State University · USGheskio Centers · HTHarvard University · USCornell University · US

Funding

Sequencing CoreU19AI109755 · NIAID · HARVARD MEDICAL SCHOOL · PI CHANDLER, DARRELL P, CULHANE, AEDIN C · 2014 to 2018
$29.1M
Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
Biomedical Research Training for VeterinariansT32OD010437 · OD · COLORADO STATE UNIVERSITY · PI Gregg A Dean, KELLY S SANTANGELO · 2012 to 2026
$6.2M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Epidemiology of multidrug-resistant tuberculosis in PeruU01AI057786 · NIAID · HARVARD MEDICAL SCHOOL · PI BECERRA, MERCEDES C · 2009 to 2010
$1.2M
Host susceptibility to Mycobacterium tuberculosis recurrence in HIV-infected peopleK23AI131913 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DUPNIK, KATHRYN M · 2018 to 2022
$964k
Mechanisms of Diabetic Susceptibility to TuberculosisK01OD016997 · OD · COLORADO STATE UNIVERSITY · PI PODELL, BRENDAN · 2014 to 2018
$615k
Modulation of immunity to tuberculosis through vitamin A-dependent nuclear receptorsR21AI144662 · NIAID · COLORADO STATE UNIVERSITY · PI PODELL, BRENDAN · 2019 to 2020
$418k
NIAID NIH HHS K23 AI131913NIAID NIH HHS R21 AI144662NIAID NIH HHS U19 AI109755NIAID NIH HHS U19 AI111224NIDA NIH HHS T32 DA013911NIDA NIH HHS T32DA013911NIH HHS K01 OD016997NIH HHS T32 OD010437NIH HHS U01AI057786NIMH NIH HHS R25 MH083620NIMH NIH HHS R25MH083620
6 · The paper itself

Abstract

backgroundAlthough previous studies have shown that vitamin A deficiency is associated with incident tuberculosis (TB) disease, the direction of the association has not been established. We investigated the impact of vitamin A deficiency on TB disease progression.

methodsWe conducted a longitudinal cohort study nested within a randomized clinical trial among HIV-infected patients in Haiti. We compared serial vitamin A levels in individuals who developed TB disease to controls matched on age, gender, follow-up time, and time to antiretroviral therapy initiation. We also evaluated histopathology, bacterial load, and immune outcomes in TB infection in a guinea pig model of dietary vitamin A deficiency.

resultsAmong 773 participants, 96 developed incident TB during follow-up, 62.5% (60) of whom had stored serum samples obtained 90-365 days before TB diagnosis. In age- and sex- adjusted and multivariate analyses, respectively, incident TB cases were 3.99 times (95% confidence interval [CI], 2.41 to 6.60) and 3.59 times (95% CI, 2.05 to 6.29) more likely to have been vitamin A deficient than matched controls. Vitamin A-deficient guinea pigs manifested more extensive pulmonary pathology, atypical granuloma morphology, and increased bacterial growth after experimental TB infection. Reintroduction of dietary vitamin A to deficient guinea pigs after established TB disease successfully abrogated severe disease manifestations and altered cellular immune profiles.

conclusionsHuman and animal studies support the role of baseline vitamin A deficiency as a determinant of future TB disease progression.

Indexed as

Latent TuberculosisTuberculosisVitamin A DeficiencyVitamin D DeficiencyAnimalsDisease ProgressionGuinea PigsHumansLongitudinal StudiesRisk FactorsVitamin AVitamin AMycobacterium tuberculosisnutritional deficiencyretinolvitamin A

Identifiers

PMID35486953
PMCPMC10200303
OpenAlexW4225258734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.